Comparison of the Pharmacological Effects of a Novel Selective Androgen Receptor Modulator, the 5alpha-Reductase Inhibitor Finasteride, and the Antiandrogen Hydroxyflutamide in Intact Rats: New Approach for Benign Prostate Hyperplasia

No AccessJournal of UrologyUrological Survey: Benign Prostatic Hyperplasia1 Dec 2005Comparison of the Pharmacological Effects of a Novel Selective Androgen Receptor Modulator, the 5alpha-Reductase Inhibitor Finasteride, and the Antiandrogen Hydroxyflutamide in Intact Rats: New Approach for Benign Prostate Hyperplasia Steven A. KaplanM.D. Steven A. KaplanSteven A. Kaplan More articles by this author View All Author Informationhttps://doi.org/10.1016/S0022-5347(01)68993-6AboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail "Comparison of the Pharmacological Effects of a Novel Selective Androgen Receptor Modulator, the 5alpha-Reductase Inhibitor Finasteride, and the Antiandrogen Hydroxyflutamide in Intact Rats: New Approach for Benign Prostate Hyperplasia." The Journal of Urology, 174(6), p. 2282 © 2005 by American Urological Association, Inc.FiguresReferencesRelatedDetails Volume 174Issue 6December 2005Page: 2282 Advertisement Copyright & Permissions© 2005 by American Urological Association, Inc.MetricsAuthor Information Steven A. Kaplan More articles by this author Expand All Advertisement PDF downloadLoading ...